United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Sep 3, 2026 · Filed Sep 4, 2026

On Sep 3, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$487.54 for US$4.63M under a trading plan, leaving 324,443 shares. Filed Sep 4, 2026 (Form 4).

Sold
9,500 shares
Price
US$487.54 average (US$479.07 to US$491.25)
Value
US$4.63M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 3, 2026Common StockOption exercise8,910US$135.42333,353Indirect
Sep 3, 2026Common StockOption exercise590US$117.76333,943Indirect
Sep 3, 2026Common StockSale200US$479.07333,743Indirect
Sep 3, 2026Common StockSale440US$480.53333,303Indirect
Sep 3, 2026Common StockSale600US$481.47332,703Indirect
Sep 3, 2026Common StockSale400US$482.35332,303Indirect
Sep 3, 2026Common StockSale80US$483.69332,223Indirect
Sep 3, 2026Common StockSale240US$485.16331,983Indirect
Sep 3, 2026Common StockSale411US$486.72331,572Indirect
Sep 3, 2026Common StockSale1,429US$487.87330,143Indirect
Sep 3, 2026Common StockSale1,604US$488.68328,539Indirect
Sep 3, 2026Common StockSale3,114US$489.62325,425Indirect
Sep 3, 2026Common StockSale940US$490.50324,485Indirect
Sep 3, 2026Common StockSale42US$491.25324,443Indirect

Source

View original at SEC

Related